The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) announced that Chief Medical Officer Yale D. Podnos, MD, MPH, FACS, will speak at the APG Spring Conference on May 28, 2026, in San Diego.
He will join a panel on Engaging More Specialists in Value-Based Care, sharing oncology-focused insights on outcomes, costs, care quality, and patient safety.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 13 | Conference participation | Neutral | +1.5% | Management participation in B. Riley investor conference with webcast access. |
| May 07 | Earnings results | Positive | -1.7% | Q1 2026 revenue and gross profit growth with narrowed net loss. |
| Apr 27 | Earnings date set | Neutral | +2.5% | Announcement of Q1 2026 earnings release date and conference call details. |
| Apr 13 | Operational milestone | Positive | +7.1% | Reported $1.8M Medicare savings and maximum quality scores in CMS model. |
| Apr 09 | Conference participation | Neutral | +0.3% | CEO and CFO participation in Needham Healthcare Conference with webcast. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
News on operational achievements and conference participation has often coincided with modest positive moves, while strong earnings have not always translated into immediate gains.
Over the last few months, TOI has highlighted multiple investor conferences and operational milestones. On Apr 13, it reported $1.8 million in Medicare savings with strong quality scores, which was followed by a solid positive price reaction. Earnings on May 7 showed strong revenue growth and a narrower net loss, yet the stock moved lower. Subsequent conference announcements, including B. Riley and Needham events, saw small gains. Today’s APG Spring Conference participation fits this pattern of visibility-focused news supporting an already improving technical backdrop.
Key Terms
value-based care medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Yale D. Podnos, MD, MPH, FACS, Chief Medical Officer, will participate in a panel discussion at the APG Spring Conference on May 28, 2026, in San Diego. The session, "Engaging More Specialists in Value-Based Care," will bring together healthcare leaders to discuss the growing role of specialists in advancing value-based care.
"Specialists play a critical role in delivering high-quality, coordinated care while helping improve outcomes and reduce the total cost of care," said Dr. Podnos. "As oncology continues to evolve, value-based models create opportunities to enhance the patient experience, maximize quality of life and survival outcomes, and improve care quality and patient safety."
Dr. Podnos will share insights on oncology's role in improving outcomes, reducing costs, and advancing value-based care delivery.
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
